What Researchers Did
Researchers reported on a series of 28 pediatric patients who experienced carbon monoxide exposures to characterize their clinical presentation and outcomes.
What They Found
Sixteen patients (57%) had potentially toxic carboxyhemoglobin (COHb) levels greater than 15%, with a mean COHb of 26.5%. An unusually high incidence of syncope (56.3%, 9/16) and lethargy (68.7%, 11/16) was observed, with all patients having COHb levels greater than or equal to 24% experiencing syncope. While 89% (25/28) of patients recovered well, three experienced delayed neurological sequelae.
What This Means for Canadian Patients
Canadian healthcare providers should be aware of the high incidence of syncope and lethargy in pediatric carbon monoxide exposure, even at moderate COHb levels. Early identification and appropriate management, including consideration for hyperbaric oxygen therapy when indicated, may help improve outcomes and prevent long-term neurological issues in children.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.
Study Limitations
As a retrospective case series with a small sample size, this study lacks a control group and its findings may not be broadly generalizable.